Valiant Laboratories IPO
IPO Details
- Open Date
27 Sep 2023
- Close Date
03 Oct 2023
- IPO
Price Range
₹ 133 to ₹ 140
- IPO
Size
₹ 152.46 Cr
- Listing Exchange
BSE, NSE
- Listing Date
09 Oct 2023
IPO Timeline
Valiant Laboratories IPO Subscription Status
Date | QIB | NII | Retail | TOTAL |
---|---|---|---|---|
27-Sep-23 | 0.00 | 0.10 | 0.62 | 0.33 |
28-Sep-23 | 0.05 | 0.29 | 1.29 | 0.72 |
29-Sep-23 | 1.04 | 1.52 | 3.14 | 2.19 |
03-Oct-23 | 20.83 | 73.63 | 16.05 | 29.75 |
Last Updated: 03 October 2023 6:13 PM by 5Paisa
Valiant Laboratories Limited IPO is all set to open from 27th September to 3rd October 2023. The company is involved in the business of pharmaceutical ingredient manufacturing with a focus on manufacturing Paracetamol. The IPO includes a fresh issue of 10,890,000 equity shares worth ₹152.46 cr. The share allotment date is 5th October, and the IPO will be listed on 9th October on the stock exchanges. The price band is ₹133 to ₹140 per share and the lot size is 105 shares.
Unistone Capital Pvt Ltd is the book-running lead manager for this IPO, while Link Intime India Private Ltd is the registrar.
Objectives of Valiant Lab IPO:
● To invest in its wholly-owned subsidiary, Valiant Advanced Sciences Private Limited (VASPL) for part-financing its capital expenditure requirements in relation to the setting up of a manufacturing facility for specialty chemicals at Saykha Industrial Area, Bharuch, Bharuch, Gujarat (Proposed Facility).
● To invest in VASPL to fund its working capital requirements.
● Fund general corporate purposes.
Valiant Lab IPO Video:
Established in 1980, Valiant Laboratories Limited is involved in the business of pharmaceutical ingredient manufacturing with a focus on manufacturing Paracetamol.
The company has its manufacturing facility in Palghar, Maharashtra, spanning over 2,000 square meters of land. This facility has an annual production capacity of 9,000 metric tons. Additionally, the company houses an R&D center featuring an analytical laboratory and resources dedicated to product development.
As of April 30, 2023, Valiant Laboratories employs a workforce of 86 individuals. The company also possesses Good Manufacturing Practices (GMP) for the production and distribution of bulk drugs/API, along with ISO 9001:2015 certification.
Peer Comparison
● Granules India Ltd
● Jagsonpal Pharmaceuticals Ltd
● Alkyl Amines Chemicals Ltd
● Laxmi Organic Industries Ltd
For More Information:
Webstory on Valiant Laboratories IPO
Particulars (in Rs. Crores) | FY23 | FY22 | FY21 |
---|---|---|---|
Revenue | 333.91 | 291.52 | 182.36 |
EBITDA | 35.09 | 42.32 | 50.00 |
PAT | 28.99 | 27.49 | 30.59 |
Particulars (in Rs. Crores) | FY23 | FY22 | FY21 |
---|---|---|---|
Total Assets | 212.76 | 181.81 | 106.31 |
Share Capital | 32.56 | 16.28 | 10.50 |
Total Borrowings | 112.26 | 110.35 | 17.73 |
Particulars (in Rs. Crores) | FY23 | FY22 | FY21 |
---|---|---|---|
Net cash generated from / (used in) operating activities | 22.96 | 2.25 | 9.10 |
Net cash from / (used in) investing activities | -21.18 | -12.24 | -16.67 |
Net cash flow from / (used in) financing activities | -1.53 | 6.18 | 11.43 |
Net increase (decrease) in cash and cash equivalents | 0.24 | -3.80 | 3.87 |
Strengths
1. The company has reported strong financial performance.
2. The company is working on reducing dependence on the import of raw materials.
3. The company’s Manufacturing Facility is strategically located near JNPT (Nhava Sheva) Port, Maharashtra and its registered office at Mulund West, Mumbai, Maharashtra, which ensures that it has ready access to port facilities and is able to expediently import raw materials and export products in a cost-efficient manner.
4. Highly experienced Management team.
Risks
1. The company solely focuses on manufacturing the paracetamol. Thus, any changes in its demand can adversely affect the business.
2. The majority of the operative income is derived from the domestic market.
3. Subject to government regulations.
4. Operates in an intensely competitive industry.
5. Pricing pressure from customers may affect the business.
6. Reforms in the healthcare industry and the uncertainty associated with pharmaceutical pricing and reimbursement could adversely affect the pricing and demand for the company’s products.
7. Restrictions on the import of raw materials may impact the business and results of operations.
8. Higher working capital requirements.
in 3easy steps
Using 5paisa App or
Website
to block Payment
Open Free Demat Account
Be a part of 5paisa community - The first listed discount broker of India.
FAQs
The minimum lot size of Valiant Laboratories IPO is 105 shares and the investment required is ₹13,965.
The price band of Valiant Laboratories IPO is ₹133 to ₹140.
Valiant Laboratories IPO is open from 27th September to 3rd October 2023.
The size of Valiant Laboratories IPO is ₹152.46 cr, which includes a fresh issue of 10,890,000 equity shares.
The share allotment date of Valiant Laboratories IPO is 5th of October 2023.
The Valiant Laboratories IPO will be listed on 9th of October 2023.
Unistone Capital Pvt Ltd is the book-running lead manager for Valiant Laboratories IPO.
Valiant Laboratories plans to utilize the raised capital from IPO to:
1. To invest in its wholly-owned subsidiary, Valiant Advanced Sciences Private Limited (VASPL) for part-financing its capital expenditure requirements in relation to the setting up of a manufacturing facility for specialty chemicals at Saykha Industrial Area, Bharuch, Bharuch, Gujarat (Proposed Facility).
2. To invest in VASPL to fund its working capital requirements.
3. Fund general corporate purposes.
To apply for Valiant Laboratories IPO, follow the steps given below:
● Login to your 5paisa account and select the issue in the current IPO section
● Enter the number of lots and the price at which you wish to apply for the Valiant Laboratories IPO.
● Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
● You will receive a mandate notification to block funds in your UPI app.
Contact Information
Valiant Laboratories
Valiant Laboratories Limited
104,Udyog Kshetra,
Mulund Goregaon Link Road,
Mulund West, Mumbai -400080
Phone: +91 2249712001
Email: complianceofficer@valiantlabs.in
Website: https://valiantlabs.in/
Valiant Laboratories IPO Register
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: valiantlaboratories.ipo@linkintime.co.in
Website: https://linkintime.co.in/mipo/ipoallotment.html
Valiant Laboratories IPO Lead Manager
Unistone Capital Pvt Ltd
Valiant Laboratories IPO GMP (Gr...
28 Sep 2023
Valiant Laboratories IPO Anchor ...
27 Sep 2023
What you must know about Valiant...
28 Sep 2023